SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-022179
Filing Date
2024-03-13
Accepted
2024-03-13 16:25:22
Documents
78
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0201577-10q_enzobio.htm   iXBRL 10-Q 742635
2 CERTIFICATIONS ea0201577ex31-1_enzobio.htm EX-31.1 9586
3 CERTIFICATIONS ea0201577ex31-2_enzobio.htm EX-31.2 9541
4 CERTIFICATIONS ea0201577ex32-1_enzobio.htm EX-32.1 2827
5 CERTIFICATIONS ea0201577ex32-2_enzobio.htm EX-32.2 2848
  Complete submission text file 0001213900-24-022179.txt   5217808

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20240131.xsd EX-101.SCH 66035
7 XBRL CALCULATION FILE enz-20240131_cal.xml EX-101.CAL 54960
8 XBRL DEFINITION FILE enz-20240131_def.xml EX-101.DEF 255343
9 XBRL LABEL FILE enz-20240131_lab.xml EX-101.LAB 533612
10 XBRL PRESENTATION FILE enz-20240131_pre.xml EX-101.PRE 269202
80 EXTRACTED XBRL INSTANCE DOCUMENT ea0201577-10q_enzobio_htm.xml XML 668201
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 24746274
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)